GlassScriptPhysician profile
Clarence Clark
NPI 1952582397
$19,441.55
in general payments reported to CMS, 2019-2025
14 companies · $41.65 in 2025
The $41.65 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $483 · 2020: $514 · 2021: $16K · 2022: $1,806 · 2023: $154 · 2024: $227 · 2025: $41.65.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $243 · Education: $180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $243.07 |
| Education | $180.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,231.36 | 2020-2024 | Da Vinci Surgical System |
| Stryker Corporation | $412.00 | 2019 | |
| Medtronic, INC. | $180.19 | 2024 | Signia |
| Covidien LP | $136.28 | 2020 | |
| Thd America, INC. | $111.46 | 2020 | |
| Conmed Corporation | $111.11 | 2020 | |
| Ethicon US, LLC | $75.28 | 2019-2024 | Echelon Flex, Echelon; Endopath |
| Davol INC. | $41.65 | 2025 | Phasix Mesh, Arista |
| Baxter Healthcare | $37.34 | 2023 | |
| Abbott Laboratories | $25.18 | 2020 | |
| Olympus America INC. | $22.69 | 2024 | Evis Exera III Colonovideoscope, Endoeye Flex Deflectable Videoscope |
| Pacira Pharmaceuticals Incorporated | $19.50 | 2020 | |
| Boston Scientific Corporation | $19.24 | 2019 | |
| Csl Behring | $18.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clarence Clark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.